Synopsys, Inc. (FRA:SYP)
Germany · Delayed Price · Currency is EUR 399.95
-21.60 (-5.12%)
At close: Jan 29, 2026
Synopsys Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 7,054 | 6,127 | 5,318 | 4,616 | 4,204 | |
Revenue Growth (YoY) | 15.12% | 15.22% | 15.21% | 9.79% | 14.08% |
Cost of Revenue | 1,312 | 1,137 | 985.56 | 853.34 | 813.32 |
Gross Profit | 5,742 | 4,990 | 4,332 | 3,762 | 3,391 |
Selling, General & Admin | 1,844 | 1,428 | 1,102 | 956.28 | 1,035 |
Research & Development | 2,479 | 2,082 | 1,850 | 1,590 | 1,505 |
Amortization of Goodwill & Intangibles | 504.38 | 70.73 | 54.58 | 56.31 | 82.38 |
Operating Expenses | 4,828 | 3,581 | 3,006 | 2,602 | 2,623 |
Operating Income | 914.93 | 1,409 | 1,326 | 1,160 | 768.2 |
Interest Expense | -446.73 | -36.83 | -2.7 | -1.7 | -3.37 |
Interest & Investment Income | 277.68 | 67.02 | 36.67 | 8.55 | 2.44 |
Currency Exchange Gain (Loss) | 1.84 | 6.29 | -1.53 | 4.69 | 5.29 |
Other Non Operating Income (Expenses) | 48.76 | 64.68 | -0.21 | -56.8 | 66.36 |
EBT Excluding Unusual Items | 796.49 | 1,510 | 1,359 | 1,115 | 838.92 |
Merger & Restructuring Charges | - | - | -53.09 | -11.22 | -33.41 |
Gain (Loss) on Sale of Investments | -3.64 | 55.08 | - | - | - |
Gain (Loss) on Sale of Assets | 600.29 | 1.91 | - | - | - |
Asset Writedown | - | -53.5 | - | - | - |
Pretax Income | 1,393 | 1,514 | 1,305 | 1,103 | 805.51 |
Income Tax Expense | 55.99 | 99.72 | 90.19 | 139.39 | 49.16 |
Earnings From Continuing Operations | 1,337 | 1,414 | 1,215 | 964.07 | 756.36 |
Earnings From Discontinued Operations | -3.9 | 821.67 | 2.84 | 14.37 | - |
Net Income to Company | 1,333 | 2,236 | 1,218 | 978.44 | 756.36 |
Minority Interest in Earnings | -1.03 | 27.57 | 11.76 | 6.16 | 1.16 |
Net Income | 1,332 | 2,263 | 1,230 | 984.59 | 757.52 |
Net Income to Common | 1,332 | 2,263 | 1,230 | 984.59 | 757.52 |
Net Income Growth | -41.14% | 84.03% | 24.91% | 29.98% | 14.02% |
Shares Outstanding (Basic) | 164 | 153 | 152 | 153 | 153 |
Shares Outstanding (Diluted) | 166 | 156 | 155 | 156 | 157 |
Shares Change (YoY) | 6.23% | 0.48% | -0.82% | -0.54% | 1.05% |
EPS (Basic) | 8.13 | 14.78 | 8.08 | 6.44 | 4.96 |
EPS (Diluted) | 8.05 | 14.52 | 7.93 | 6.29 | 4.81 |
EPS Growth | -44.58% | 83.13% | 26.01% | 30.81% | 12.65% |
Free Cash Flow | 1,349 | 1,268 | 1,514 | 1,602 | 1,399 |
Free Cash Flow Per Share | 8.14 | 8.13 | 9.75 | 10.24 | 8.89 |
Gross Margin | 81.41% | 81.44% | 81.47% | 81.51% | 80.66% |
Operating Margin | 12.97% | 23.00% | 24.94% | 25.13% | 18.27% |
Profit Margin | 18.89% | 36.94% | 23.13% | 21.33% | 18.02% |
Free Cash Flow Margin | 19.13% | 20.69% | 28.46% | 34.71% | 33.27% |
EBITDA | 1,328 | 1,599 | 1,526 | 1,343 | 921.76 |
EBITDA Margin | 18.83% | 26.10% | 28.69% | 29.10% | 21.93% |
D&A For EBITDA | 413.22 | 190.27 | 199.46 | 183.15 | 153.56 |
EBIT | 914.93 | 1,409 | 1,326 | 1,160 | 768.2 |
EBIT Margin | 12.97% | 23.00% | 24.94% | 25.13% | 18.27% |
Effective Tax Rate | 4.02% | 6.59% | 6.91% | 12.63% | 6.10% |
Revenue as Reported | 7,054 | 6,127 | 5,318 | 4,616 | 4,204 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.